CN Patent

CN120225521A — Akt1调节剂

Assigned to Atrom Medical Co · Expires 2025-06-27 · 1y expired

What this patent protects

本文提供了AKT1的抑制剂、包含抑制性化合物的药物组合物以及用于使用AKT1抑制性化合物治疗疾病的方法。

USPTO Abstract

本文提供了AKT1的抑制剂、包含抑制性化合物的药物组合物以及用于使用AKT1抑制性化合物治疗疾病的方法。

Drugs covered by this patent

Komzifti (ZIFTOMENIB) · Kura

Patent Metadata

Patent number: CN120225521A
Jurisdiction: CN
Classification: —
Expires: 2025-06-27
Drug substance claim: No
Drug product claim: No
Assignee: Atrom Medical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.